AAN Board of Directors slate announced
Proposed 2025‒2027 AAN Board of Directors slate nominees announced
The AAN Nominations Committee, chaired by James C. Stevens, MD, FAAN, has announced the slate of nominees for AAN officer and director positions for the 2025–2027 term.
Officers
Directors
*New to the Board
The current President Elect, Natalia S. Rost, MD, MPH, FAAN, FAHA, will begin her term as President on April 10, 2025. The current President, Carlayne E. Jackson, MD, FAAN, will then serve on the Board of Directors as Immediate Past President.
View biographies of the ex officio AAN directors and the AAN Institute directors below.
Ex Officio Directors
-
Bruce H. Cohen, MD, FAAN
Chair, Advocacy Committee/ex officio
-
Nimish A. Mohile, MD, FAAN
Chair, Diversity, Equity, and Inclusion Committee/ex officio
-
David A. Evans, MBA
Chair, Brain Health Committee/ex officio
-
José G. Merino, MD, MPhil, FAHA, FAAN
Editor-in-Chief of Neurology®/ex officio
-
Maisha T. Robinson, MD, MSHPM, FAAN
Chair, Member Engagement Committee/ex officio
-
Melissa Yu, MD, FAAN
Chair, Medical Economics and Practice Committee/ex officio
-
Mary E. Post, MBA, CAE
Chief Executive Officer/ex officio, non-voting
The Academy is comprised of two legal entities, the AAN and the AAN Institute. Most of the elected members of the AAN Board of Directors also serve ex officio on the Board of Directors of the AAN Institute, which includes an independent secretary-treasurer and additional members who serve in ex officio capacities. The AAN Institute Board of Directors will include the following additional members:
AAN Institute Board of Directors
The slate of nominees will be presented to the voting membership for approval during the 2025 AAN Business Meeting on Saturday, April 5, from 3:30 p.m. to 4:30 p.m. PT during the Annual Meeting.
For more information, contact Karen Kasmirski, Senior Governance Coordinator.